MedTrace Logo

Mitral Valve Repair With the Chord-X System: A Long Term Evaluation

NCT07413926 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2026-02-20

No results posted yet for this study

Summary

The goal of this clinical trial is to strengthen the evidence available for the Chord-X System by collecting follow-up data from patients who underwent Chord-X implant and to evaluate the long-term safety and performance data (out to 10 years). Collecting patient health information over time can help to supplement and improve the care of patients in the future.

Participants will:

Agree to the collection of their past medical history, and the details of their mitral repair surgery with the Chord-X system, including results of the follow-up examinations after implantation Visit the clinic for the routinely scheduled follow-up examination appointments

Conditions

  • Mitral Regurgitation (MR)

Interventions

DEVICE

Chord-X system implant

Patients, who underwent a mitral valve procedure, using the Chord-X System as clinically indicated, whose surgery occurred beginning in January 2022

Sponsors & Collaborators

  • Artivion Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph Zacharias, MD

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2034-03-31
Completion
2034-06-30
FDA Device
Yes

Countries

  • United States
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07413926 on ClinicalTrials.gov